Eom Pharmaceutical Holdings Inc (IMUC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,791 | -7,981 | -4,580 | -1,425 | -9,378 |
| Depreciation Amortization | 36 | 20 | 13 | 7 | 48 |
| Accounts payable and accrued liabilities | 805 | 536 | 130 | 171 | -645 |
| Other Working Capital | -4,498 | -3,699 | -871 | -164 | -794 |
| Other Operating Activity | -2,592 | -2,100 | -1,600 | -1,638 | 832 |
| Operating Cash Flow | $-19,039 | $-13,224 | $-6,908 | $-3,049 | $-9,937 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | -170 | -6 | -2 | -29 |
| Investing Cash Flow | $-170 | $-170 | $-6 | $-2 | $-29 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 14,600 | 14,606 | 14,600 | N/A | 4,496 |
| Common Stock Repurchased | 7 | N/A | N/A | N/A | 1,045 |
| Other Financing Activity | -15 | 0 | 0 | 14,600 | 0 |
| Financing Cash Flow | $18,591 | $14,606 | $14,600 | $14,600 | $5,541 |
| Beginning Cash Position | 23,222 | 23,222 | 23,222 | 23,222 | 27,646 |
| End Cash Position | 22,605 | 24,435 | 30,908 | 34,771 | 23,222 |
| Net Cash Flow | $-618 | $1,213 | $7,686 | $11,549 | $-4,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,039 | -13,224 | -6,908 | -3,049 | -9,937 |
| Capital Expenditure | -170 | -170 | -6 | -2 | -29 |
| Free Cash Flow | -19,209 | -13,394 | -6,914 | -3,051 | -9,966 |